FiercePharmaAsia—Takeda-Novartis Xiidra deal; Daiichi-AZ's HER2 ADC; Sun Pharma eyes China

10th May 2019 Uncategorised 0

Takeda sells dry-eye drug Xiidra to Novartis and offloads TachoSil patch to Johnson & Johnson. Daiichi Sankyo’s HER2 antibody-drug conjugate, shared with AstraZeneca, meets its goal in a pivotal trial. Sun Pharma scouts for a partner to expand into China. And more.

More: FiercePharmaAsia—Takeda-Novartis Xiidra deal; Daiichi-AZ's HER2 ADC; Sun Pharma eyes China
Source: fierce